Skadden is representing Merck KGaA (Germany) in the US$6.7 billion sale of its worldwide generic drugs business to Mylan Laboratories Inc., a pharmaceutical company.
Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates
Skadden is representing Merck KGaA (Germany) in the US$6.7 billion sale of its worldwide generic drugs business to Mylan Laboratories Inc., a pharmaceutical company.